Age
Item
Ages Eligible for Study: 18 Years to 65 Years (Adult)
boolean
C0001779 (UMLS CUI [1])
Schizophrenia or schizoaffective disorder
Item
Diagnosis of schizophrenia or schizoaffective disorder
boolean
C0036341 (UMLS CUI [1])
C0036337 (UMLS CUI [2])
Remission
Item
The participants have to be in remission for at least 3 years (i.e. no psychiatric hospitalisation) under a stable antipsychotic medication. Remission will be measured using the remission criteria by Andreasen et al. (2005) Score ≤3 for the items concerning psychosis of the "Positive and Negative Syndrom Scale" (PANSS; Kay et al., 1987): "Delusions" (P1), "Conceptual disorganisation" (P2), "Halluzinations" (P3), "Mannerisms and posturing" (G5) and "Unusual thought content" (G9) and a score ≤3 on the "Clinical Global Impression Severity Scale" (CGI-S; Guy, 1976)
boolean
C0544452 (UMLS CUI [1])
Informed Consent
Item
Able to give informed consent
boolean
C0021430 (UMLS CUI [1])
Control Group
Item
Healthy Volunteers
boolean
C0009932 (UMLS CUI [1])
Suicidal tendency
Item
Actively suicidal
boolean
C0235196 (UMLS CUI [1])
Comorbidity
Item
Serious medical illnesses
boolean
C0009488 (UMLS CUI [1])
Compliance
Item
Known non-complience concerning the medication
boolean
C1321605 (UMLS CUI [1])
Clozapine
Item
Medication with clozapine
boolean
C0009079 (UMLS CUI [1])
Antidepressants and Mood Stabilizer
Item
Medication with antidepressants and mood stabilisors that were initiated during the last 6 weeks before study enrollment
boolean
C0003289 (UMLS CUI [1])
C2917435 (UMLS CUI [2])
Substance Use Disorder
Item
Patients with substance dependence other than nicotine or caffeine within 6 months prior to baseline
boolean
C0038586 (UMLS CUI [1])
Unability to give informed consent
Item
Unability to give informed consent
boolean
C1299582 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
Pregnancy
Item
Pregnancy
boolean
C0032961 (UMLS CUI [1])